The Role of Baseline Neurological Health in Swallowing Recovery After Stroke
36 minAudio
What does pre-stroke neurological health have to do with swallowing prognosis, post stroke? In this episode, Dr. Janina Wilmskoetter, Assistant Professor at the Medical University of South Carolina, discusses her recent publication, Cerebral Small Vessel Disease is an Independent Determinant of Dysphagia After Acute Stroke. Join us for insights into clinical implications for patients with dysphagia! For questions, reach out to Dr. Wilmskoetter at wilmskoe@musc.edu, and access the article via https://www.sciencedirect.com/science/article/pii/S2213158224001517 Episode Sponsor: Bracco Diagnostics, the manufacturer of Varibar barium sulfate products. The only FDA-approved products for the Modified Barium Swallow Study Learn more at https://bracco.com or https://varibarmbs.com Upcoming Live Webinar (2/23/25): Don’t forget to check out Swallowing Cinema, a long-standing MBS case study event at ASHA, now hosted by Gap Education Access at https://gap.learnworlds.com/course/cinema1 https://www.swallowthegap.com/livecourses Gap Education: https://swallowthegap.com Instagram: https://www.instagram.com/swallowpatho
Audio and video play straight from the show's own hosting. PodSubs stores and serves no media.
Transcript
From the show. Tap a time to play from there.
Speaker 1Today's episode is sponsored by Braco Diagnostics, the manufacturer of Verabar barium sulfate products, the only FDA-approved barium products for the modified barium swallow study. Learn more at Braco. That's B-R-A-C-C-O dot com or VerabarMBScom. Welcome everybody. This is Dr Janina Vimskota. She's an assistant professor at the Medical University of South Carolina and you can't see her, but she's laughing at me at my production of her name because I'm trying so hard and apparently it's not good enough.
Speaker 1Janina, is that right?
Speaker 2Nor is it just too perfect. It was fantastic. Yeah, I love it, even better than the German pronunciation.
Speaker 1Even better. I'm trying so hard, Trying so hard, trying so hard. But Janina, she works as a researcher, an instructor and in the clinic in an acute care clinic at the Medical University of South Carolina. We recently recorded an episode with Julie Blair, who also is at the Medical University of South Carolina, so check that one out too. But that's not why we're here today, Janina. Why are we here? You published something. Tell me about it.
Speaker 2I did. It just came out actually. So it's an article that's titled Cerebral Small Vessel Disease is an Independent Determinant of Dysphagia After Acute Stroke. I had to read this right now. It's not that I remember that by heart.
Speaker 1Yeah, so then there are a lot of words. So Cerebral Small Vessel disease is an independent determinant of dysphagia after acute stroke. So I'm guessing that's what you found. Just a guess.
Speaker 2I learned, like from a professor, like if the title is a question and it's very, very likely that they didn't find what they were looking for, and here we already give the answer. So you actually don't have to read the article. If you don't have time, just read the title. Nice, not even the abstract. You don't have to read the article. If you don't have time, just read the title.
Speaker 1Nice, not even the abstract. You don't have to dig that. No, no.
Speaker 2Just the title, yeah.
Speaker 1We've got a lot of names of people on here who have worked with you Bonnie Martin Harris I recognize that one. Yeah, no, this is fantastic. It looks like a collab between the University of South Carolina Northwestern and the Medical University of South Carolina.
Speaker 2Yeah, I was lucky because when I did my PhD at the Medical University of South Carolina years ago, dr Heather Bonilla, leonardo Bonilla and Bonnie Martin Harris were on my committee. So I was really, really fortunate, and this data that I've analyzed was actually part of the patient data that I collected at that time. It's expanded out of it.
Speaker 1So, yeah, very cool, very cool. So it's a very an interesting subject and, as I was looking through it, I like the fact that it not only looked at like new stuff. You know, someone has a stroke. You're looking at these people who had their first stroke, but you're looking at all of these premorbid indicators. So I'm very curious about what prompted you to do this. What was going through your head?
Speaker 2Right, this is a really good question. It's like oh, there are nice pictures in the article, but why do we need this? So I worked as a clinician many years in acute care and my passion is like stroke, so neurological injuries. And when I worked as a clinician and still do there can be like two patients with the same stroke lesion location. So on paper they look pretty the same, but then you walk into the room and they present really differently.
Speaker 2One patient has dysphagia, the other one doesn't really present with dysphagia. And my prior work in my dissertation looked at how much can we understand from the lesion location, lesion size etc. To predict what swallow physiological impairment is there. So my entire dissertation was on let's look at the lesion location and see what impairments are correlated with this. But in clinic, to some degree we can use that information. But then we see these patients.
Speaker 2Well, they have the same lesion location but they present differently. So there must be something else that contributes to why some patients present with more severe or with no dysphagia. And there are of course lots and lots of different factors. But one factor that we understand from our recent literature overall in stroke seems to be the brain health before the stroke. So how healthy is the brain that then gets an injury and that has been looked at in other stroke functions like language, so aphasia or motor recovery, and there seems to be really good correlation that it is a contribution of like how healthy you go into the stroke.
Speaker 2What kind of makes sense thinking also about analogies like if you have pneumonia in a pretty healthy lung, that's probably not as damaging or detrimental compared to someone who already has COPD or other damage to the lung then gets pneumonia on top of that, this person will probably struggle more in terms of the severity or recovery. And that's what this brain health term tries to get at when we think about like a brain can be structurally more healthy or more diseased, but also this will turn also into the function that the brain can be structurally more healthy or more diseased, but also this will turn also into the function that the brain can produce.
Speaker 2So that's kind of the idea If things can explain, or help us explain, how someone presents after a stroke that relates to their brain health before the stroke.
Speaker 1And you do a great job at explaining that. Like I feel like I'm following right along and so that brings me to like if you're working with someone with pulmonary issues and has dysphagia, there are things like you mentioned COPD that you look for. So you look in their medical history. You'll look in the chest x-ray or chest CT reports to get a better idea of some of those chronic issues that may impact their, their healing and recovery. What types of things did you speculate or what types of things did you look into that would be similar markers for neurological health?
Speaker 2oh yeah, so for, and of course, there's not like one definition of like this is how we should measure brain health.
Speaker 1It's a healthy brain. Looks like this Healthy brain.
Speaker 2Like so what is a healthy brain? And hey surprise, everybody has a different definition for that. And then we took a definition that has been more recently used, also in like standard radiology guidelines, and this is small vessel brain disease. This is just one marker how the brain structure changes over time with age. Other functional definitions could, for example, be, I don't know, intelligence right. Is that maybe a marker for healthier brains, someone who is more intelligent?
Speaker 2But how do we measure intelligence? So we can like have these discussions. We only looked at structure in the brain, and cerebral small vessel disease is one marker that is like a standard measure, and you will see that in your MRI reports of any patient that you have in the hospital who got a brain MRI and often it's something worded like T2 hyperintensities or unspecified T2 hyperintensities, likely cerebral small vessel disease.
Speaker 2So this is like kind of the terminology that you will see. But the big thing is that based on that, you normally don't get information on how severe is that. Is that just really mild? Is that something I should care about? Sometimes you might see expressions like atrophy in the MRI, but the interesting thing that when I started with this research is that there's a huge variability, huge variance about how a brain ages Kind of makes sense, but I never like translated that.
Speaker 2Yeah, the brain as well, and some of the normal, normal things that happen when we get older, no matter if there's an underlying disease or not, is that? Yep, our brain atrophies, so the gray matter, white matter, shrinks and that's counterbalanced by an increase in cerebrospinal fluid and that's what we term atrophy. So, yes, we all go through that, no matter how healthy or unhealthy we are. But the crux to that is that it's very variable.
Speaker 2So two people who are 80 years old can have a very different degree of atrophy. So one person might have severe atrophy and the other person doesn't. And I think you can again translate that to someone who's 80 and really active. I heard some people still run, like I don't know, half marathons a minute. It's probably not going to be me. But there's, a huge variance of like how people age, and that's the same idea with a brain age and that's the same idea with the brain.
Speaker 2So cerebral small vessel disease is a term that encapsulates like many different structural pathologies in the brain. Atrophy is one, micro hemorrhages, so like little tiny bleeds in the brain, and then another marker of cerebral small vessel disease is something that's called white matter hyperintensities, and it's exactly what the name says. When you look at a brain scan, a specific brain scan, that's T2 or flare, they look just really bright because these are areas that look white compared to the other tissue and we can go more into what that might be.
Speaker 2And then also something like called perivascular spaces, and these are just spaces around the arteries that perforate the brain. So, as you can imagine, so these spaces around the arteries, they are filled with fluid and the larger they are, they take up more space in the brain and it seems to be a marker that the brain might not be as efficient to drain some of the dust or the debris in the brain tissue.
Speaker 2So all these things are like different markers that the brain has several small vessel disease. So to the small vessels in the brain, that they are not functioning as well as they might did when we were younger. But the thing is really like how much does a person have that? We're probably all going to have it at some point, but some people will have it more than others. And these are findings that are typical incidental, so you don't know that you have that until you get a brain scan.
Speaker 2Incidental, so you don't know that you have that until you get a brain scan. I was like, oh wow, there's a lot of white matter, hyper intensities, and so, while it's not something that you feel from one day to the other, it is something that probably contributes over time to specific functions like swallowing or memory, because it's one of the major contributions to also people developing dementia.
Speaker 1Yeah, so I know people who are listening to this, probably in their car and in a place where they can't really like sit down and look at a diagram, but this article is open access and I would highly recommend taking a look at some of the images in here. These are fantastic. So the comparison so you were talking earlier about the increased volume of cerebrospinal fluid, that kind of compensates for the brain atrophy, like you get brain atrophy, and so the parts of your brain let's I don't I want to say that matter, but that maybe that makes us smart or healthy?
Speaker 2Gray matter and white matter. Tim, Was that a pun?
Speaker 1There you go, that matter. No, it it yeah. Yeah, sure it was. I guess I'll pretend that it was, but so you know, as you get atrophy of those, then you get more cerebrospinal fluid in there. So figure two is super cool. There is patient one, 68 year old female 0.25 liters of cerebrospinal fluid. And then patient two, also 68 year-year-old female, was a little over twice that. You can tell the difference. This is so interesting. So if you get a chance, take a look at figure two. A quick reminder of our sponsor. Braco is a global leader in diagnostic imaging, dedicated to providing you with the most advanced tools and diagnostic imaging solutions.
Speaker 1Find out more at Bracocomcom or verabarmbscom.
Speaker 2And you know I've never learned as a speech-language pathologist to look at MRIs, right? So I was fortunate to learn that during my PhD and postdoc. But it is also interesting that the people or the patients that we included in the study, they all were pretty clean cohort. So, first ever ischemic stroke. We excluded anyone with, like, prior diseases that could relate to dysphagia. So no neurodegenerative diseases, no head and neck cancer, no other stroke before that, no TBI, right?
Speaker 2So all these these like typical things. So these are supposedly people who were healthy before they had the stroke. But again, all this, what we see in these like examples, were pathologies that were there before the stroke. So it's not something that's related to the stroke because these patients were acute stroke patients. It was something that was there already before the stroke, but again, not something that was apparent because it didn't cause acute symptoms.
Speaker 1Yeah, and maybe not even something that people would recognize symptomatically over time. So like if you're interviewing someone's family, you'd be like, well, did they have dementia before this? They might not have any indication of memory loss, so you might not get it without this imaging.
Speaker 2Yeah, correct. And I mean it's not something that we would. I think it's like human nature, right, If we don't feel limitations, not functional loss, so why should we look into that, right? Sure yeah.
Speaker 1Well, that's fascinating to see where that kind of comes to bite you later. For sure, yeah, so as a clinician, because you worked as a clinician for a while before getting your PhD. Is that right?
Speaker 2Mm-hmm. Yes.
Speaker 1So I figured this was pretty clinically driven. What are some of your takeaways, Like how do you think you're going to use this from now on?
Speaker 2Yeah, great question. So what is always the best question I got as a researcher right? Well, it's great research. But so what? I think it helps me as a clinician when you do a chart review and we do that thoroughly. I think we are used to looking through like doctor's notes. We look at chest imaging, we read the notes from the MRI or CT, what we have. I hope it helps to get a better hypothesis of what you might see when you walk into the room.
Speaker 2And I think it's also we haven't proven that yet, knock on wood that this research is continuing, but it will likely be a marker for recovery as well.
Speaker 1That's what I was going to. Prognostic indicator potentially. Oh wow, there you go.
Speaker 2There we go. So we showed that in aphasia actually so language disorders after stroke that patients with worse brain health, measured as cerebral small vessel disease, had worse potential to recover despite treatment. So, and that's controlling for their chronological age. What's really fascinating? So it's not the chronological age, it's really the brain age. So how healthy is the brain at the time they receive treatment?
Speaker 2And so if you walk into a room and patient presents with dysphagia, then it's always the question of doctors hey, so do you think this patient recovers or do we have to think about putting a feeding tube in because we really want to discharge this patient? And then, as a SLP, I always feel like I wish I had an answer, but why don't I have an answer? And I think this is a factor that comes into play that we can say, yeah, okay, so the stroke location.
Speaker 2We know this will lead to whatever severity of dysphagia. That's what we're going to see at bedside. And if we have an idea of the patient's status before their stroke how healthy were they, how healthy was their brain before the stroke this can help us to say, oh, the chances are actually really good for this patient to recover because they had a pretty good brain structure before that. So that's, I think, lends to our discussion, tim, about the reserve that someone has to recover.
Speaker 2So how much capacity does a patient bring to, for example, the brain for the brain to reorganize after a stroke? So what we know from dysphagia literature and Shaheen Hamdi I love his research and his group around that brought us a lot of knowledge that after dysphagia, after dysphagia in one hemisphere, the other hemisphere is likely to help a lot in recovery and also like areas around the stroke. But imagine if those areas that were not affected by the stroke but are supposedly to help with recovery if they are not healthy, then the brain won't have the same capacity to reorganize or regain that function compared to a brain where these unaffected areas were pretty healthy and had a lot of white matter connections, had a really good volume of gray matter.
Speaker 2So we're just like there are more neurons that can change. I hope that made sense. Did this make sense?
Speaker 1Somewhat. No, no, you're making sense, but my brain's also going in different directions with questions and I'm like I'm afraid to ask these questions because I should probably know some of these answers and like it's probably already been studied before. Well, who knows, who knows, I guess I got to put myself out there some, but I mean I'm thinking of so as I understand, kind of what you're saying, and I'm also I'm looking at another one of these beautiful images. It is figure four. So this is cool. Figure four has it highlighted the corticobulbar tracts in the right and left hemisphere, going over from the motor cortex down toward the brainstem, and it shows different lesion sizes and different lesion locations and on this it's showing some of them, basically, uh, the lesions covering where the corticobulbar tracts would be.
Speaker 1And so, as you're talking about the recovery, like the, so say, if the left side is affected, the health of the as I understand what you're saying the health of the right side of the brain and its ability to kind of take over some of these functions. Well, I mean, the premise being is that it will help to compensate, and the healthier it is, the better it's going to be able to compensate, right, that's what I'm getting. So I'm thinking about all these poor folks with spastic dysarthria who they have like bilateral damage to the corticobulbar tract. I'm so sorry and so like thinking of that as a prognostic indicator.
Speaker 1I'm sure there's probably research out there that says that, that I should know, that I don't, don't know enough about at least and tim.
Speaker 2Let me plant a seed for the audience, because I saw that you had the post about dysarthria, and dysarthria are not my strengths, though I love the post that you included in your instagram, I think oh, thank you.
Speaker 1Yeah, no, I I've been. Dysarthria has been very interesting to me, of the various types of dysarthrias, and I was very fortunate to be able to start teaching this course at the University of Hawaii. But it's not. Unfortunately I didn't get to go there, it's remote, but I learned so much. So Dr Kendrea Grand, as you can imagine, has a very robust dysarthria course or motor speech disorders course put together and so she sent me her materials and I got to look through them and get some other things.
Speaker 1But I learned so much going through that and just like the parallels with dysphagia treatment, the upper motor neuron or bilateral upper motor neuron lesions causing spasticity, and how you might treat that differently than somebody who has a lower motor neuron lesion and I. The analogy I use is like you've got a cord coming from your power outlet going to a lamp and someone just cuts the cord Like it's not getting power anymore. So just the flaccidity, the weakness, that type of thing. But so you see, like I can see so many parallels between this and dysphagia.
Speaker 1So it's just like my world has been blown up in that perspective lately.
Speaker 2So I think it's, I just think it's super cool, I very much, and I because my background is also like in aphasia. So language disorders I often compared also like how is recovery working in aphasia, compared to dysphagia, dysarthria, and I think what is really striking is like how much in these functions do both hemispheres contribute? So we know that the typical language organization in the brain is heavily towards the left side of the brain. In those typical people, right hand, dominant etc. The right hemisphere is also involved in language processing, but not as much More like in the ventral stream.
Speaker 2So semantic processing et cetera, with swallowing in comparison and speaking. We know it's a bilateral neural network and it's less lateralized. So language is a heavily lateralized function, swallowing not so much. So both hemispheres contribute. And how I think about it is it's actually great when it's really organized in both hemispheres because that means there's one hemisphere, the redundancy.
Speaker 2Exactly so. If you have an injury, then the other hemisphere, because it already contributes to that function. It will be easier for the hemisphere to okay. I'm just going to do a little bit more. I already have these connections, I already kind of know what I have to do. In comparison to something like language that's heavily lateralized to the left, the right hemisphere does a little bit, but not as much. So that's why the oral hemisphere and language has a more difficult time to compensate. So we don't see that as much and the areas around the stroke are more contributing in language for recovery.
Speaker 2And that's why it's interesting when you pointed out the figure four, I think long, long time you always think okay, brainstem is swallowing right Corticobulbar tract. That's really, really important. We know that and lots of those studies that look at recovery also look at corticobulbar tract. Makes sense.
Speaker 1Oh, and real fast. Just I don't want to assume anyone knows anything. Corticobulbar tract the motor neurons coming from the cortex to the brainstem. So I think corticobulbar is cortex to brainstem, corticospinal is cortex to spine.
Speaker 2So for motor neurons, yes, thanks, tim, that's right.
Speaker 1I mean, you probably didn't know that either, but I'm just showing off. You just study it for a living, yeah.
Speaker 2I was told, so I lost my train of thought.
Speaker 1No, oh, dang on, I'm sorry.
Speaker 2In this figure. So corticobulbar tract, and in the study that we did with a cerebral small vessel brain disease, we controlled for the stroke damage to these important tracts, corticobulbar tract. So we just wanted to make sure that we can like isolate the contribution of the cerebral small vessel disease, no matter how much or how little the corticobulbar tracts were lesioned, no matter how large the stroke is, no matter how old someone is, et cetera, et cetera. And from some other literature we also know that, yeah, corticobulbar tract is important, but that's not the only connection the cortex has to the brainstem.
Speaker 2What is also really really interesting and I hope that some neuroscientists who can do much better work than I can do, will tell us a little bit more about that in their future research so what other tracts than the corticobulbar tract can we maybe stimulate through electrical stimulation or whatever? That could then even compensate if the corticobulbar tracts are damaged.
Speaker 1That's super cool. It's like cracking open a whole other pathway for dysphagia rehabilitation. That's super neat.
Speaker 2Pathway Again.
Speaker 1A pun Tim oh see, it's above my head over my head. I'm going to have to listen to that again and be like all right, I got to learn from those accidental puns. So you were comparing the idea of of language dominance, which is typically more isolated to one hemisphere than the other, at least relative to swallowing, and so that I guess the kind of a question I'm going to throw back at you right, that is, if we're also understanding the cranial nerves that are involved in swallowing and the upper motor neuron tracks that eventually lead to these cranial nerves.
Speaker 1And the ones that I and this oversimplification, I'm sure the ones that I look at primarily trigeminal, five, facial seven, glossopharyngeal, nine, less from a motor perspective, but vagus 10 and then accessory yeah, hypoglossal, I was going to go, I kind of accessory, yes, yes, of course, but I'm going more like direct, but, yeah, hypoglossal, I was gonna go, I, I kind of accessory, yes, yes, of course, but I'm going more like direct, but, yeah, hypoglossal. So, knowing so, I think so many, we learn that like, okay, brain, right hemisphere controls the left, left hemisphere controls the right, but knowing the importance of which one of those, which of those cranial nerves are also bilaterally innervating?
Speaker 1You like the face like the facial nerve, especially the upper face. You get bilateral innervation from that. So in looking at and trying to hypothesize imaging to function and that sort of thing, just the importance of knowing which of those nerves provide bilateral innervation.
Speaker 2Yeah, that is so interesting, right. And then the hypoglossal nerve again hypoglossal nerve. It's always so fascinating to me that some people naturally have a really prominent bilateral representation and some people have it more unilateral. So that's why, you see, in some cortical stroke patients some have a tongue deviation and others don't, because there's like this mix, oh yeah. Yeah, exact physiological mix Like I don't know's like this mix. Yeah, exact physiological mix like I don't know. Tim, do you have it bilateral? I hope I do, but we don't know yeah, I don't know.
Speaker 2Hopefully we won't ever find out, but yeah, we'll see and I think for dysphagia, cranial nerves are so important and they give us so much information at bedside to then come up with hypotheses. And again, a shout out to dr garland who has so much knowledge about this and has so many great educational platforms to help us understand that in dysphagia, I think what we then, taking it a step further, often also need to consider is, of course, the coordination piece.
Speaker 2Right, so cranial nerves tell us, like the information directly to the muscles, can we like switch this on off? But it doesn't tell us if the muscles work in synergy, because that needs to be controlled by other areas in the brain that are not, that are not those corticobulbar tracts that give rise to the nerves, and I think that's then, of course, always the interesting piece. It's like, okay, they don't have cranial nerve damage, but present with severe dysphagia, yeah, because there are other areas in the brain that help with this coordination piece.
Speaker 1Like the extrapyramidal system, the basal ganglion cerebellar control circuits.
Speaker 2Exactly.
Speaker 1And those are so complicated. Oh yeah, like I, oh yeah, there's just I'm just scratching the surface with those there's. To me they appear so much more complicated than just the direct activation pathway or the, you know, the corticobulbar and the corticospinal.
Speaker 2Right, yeah, I think that's why many researchers or many studies, and we as well, look at the corticobulbar tract because it's kind of like, okay, I get it, I get it, but yes, there are many other areas in the brain and circuits are contributing to swallowing that.
Speaker 1That's cool. That's cool, I'm having fun. I'm having fun. This is why I do the podcast, like I learned so much, and just have fun conversations. I mean, this is one reason why I do the podcast. The post-production editing, that's a whole different story. But this is this is I'm happy as a clam, happy as a clam, right now.
Speaker 2I am so thrilled that I can talk here today because I'm kind of a fan girl of your podcast, so thanks for having me.
Speaker 1I appreciate it. No, this is so. Janina and I met at the hard to swallow catalyst for change in dysphagia management conference. It was two years ago. That was a great year. I think that was the biggest turnout that we had. That was so much fun. Don't know the date for that yet and that's done through Rocky Mountain University, not through, not through, gap education, my company. But oh, there is a plug though. There is a plug real fast. I got to take advantage of this, of this. You're talking about dr kendria garant and her marvelous work on cranial nerve stuff. So in march we are going to have, or we're planning march either early march or late march to have a three-hour webinar with her to really dive into that stuff, hoping to record it too.
Speaker 1So mark your calendars, keep that open.
Speaker 2No, you know I'll be there, yeah.
Speaker 1Well, we'll all be there, right, where are you going to be? So, anyway, that's that, but not to sidetrack us too much. We talked about why you did this study. Why do we care? Why should we care? The clinical translation cerebral small vessel disease is a standard measure of health potentially related to the brain. What do you think are some of the limitations of the study?
Speaker 2Like what? Should we not read the study and be like all right, this means this now? Yeah, thanks for that question. So this study was a preliminary study, right, and I feel like every study can be titled a preliminary study, because always we want to do more. So we only had 40 participants and of course, the goal is that we increase the sample size by a lot and then continue also the measures in a more sophisticated way. So what the readers will see is like, for example, the perivascular spaces and white matter hypotensities.
Speaker 2We scored them on an ordinal scale and there are way better ways to do this in a more quantitative way. So so take this with a grain of salt. But was that right video? Great, okay. And so while we did a lot of analyses, only very, very few survived in the end to be statistically significant, and even fewer survived after very stringent corrections for multiple comparisons.
Speaker 2So it's the way that we need to do is that we don't think some of our results are true, even though they might just be an accidental finding or an artifact. So the limitation is definitely a small sample size, and it doesn't mean that just because we didn't find something that it's not there. I think that's what's important. For example, we didn't find a significant correlation between these measures and oral total. That was something I was expecting, so I was thinking, okay, these aging factors.
Speaker 2I think what we often see is like oral control difficulties. We didn't find that. However, it doesn't mean it's not there, right. Just because it wasn't statistical significant doesn't mean that it's not there. So we have to just keep that in mind, that maybe our sample wasn't big enough, maybe our measurements were not as sensitive as they should be. So I think this is really important when you read that study, to keep that in mind. And I feel like that we as clinicians are not trained to do these measures that we used in the study right.
Speaker 2I think I had no idea what perivascular spaces are before I did this and absolutely no idea how they would look like. So it's going to be difficult for clinicians to really know in the patient that they see if these things are present. But just really look at the MRI report and look for these words like unspecified T2 hyperintensities likely related to cerebral small vessel disease. So I think that's my recommendation Look for these things and start like thinking about oh, this might mean that the brain health of this patient wasn't as great to begin with.
Speaker 1Yeah, did.
Speaker 2I answer your question, Tim. Oh, and more.
Speaker 1Yeah, okay, that's great. Oh, with yeah, did I answer your question, tim? Oh and more. Yeah, okay, that's great. Oh, thank you so much. Is it anything else that you want to leave listeners with?
Speaker 2No, I think I feel like the clinical driven questions are what is really important to me. So if anybody else has clinical questions, I think that's the way to go, that we should then research to get more answers for when we practice clinically.
Speaker 1Good deal. Good deal, and it looks like your email address is also listed within this article, so if I put it out there, I don't feel quite so bad. W-i-l-m-s-k-o-e at M-U-S-C like medical university of South Carolina, dot E-D-U. All right, cool. Well, thank you very much, really appreciate it. It's great to see you. This makes me want to have you do a three hour course after Kendra, I don't know sometime. So we got to talk about that, talk about that Hang out, and maybe we'll get something going.
Speaker 1We'll see, but thanks again everybody. Dr Janina Wilmskota Right, okay, okay, I'm very self-conscious of my pronunciation.
Speaker 2Yeah, thanks so much, tim.
Speaker 1Awesome, thank you. That was Dr Janina Wilmskota discussing cerebral small vessel disease as a predictor of recovery and dysphagia after acute stroke. You can reach her at Wilmskoe, that is W-I-L-M-S-K-O-E, at M-U-S-C. Dot E-D-U, that's M-U-S-C like Medical University of South Carolina, and there's a link to today's article in the episode description. Don't miss our upcoming event on February 23rd, swallowing Cinema.
Speaker 1It's an MBS case study event that has been a staple at ASHA for years and this year it's found a home with us. Visit SwallowTheGapcom or SwallowTheGapcom slash live courses to learn more. Thanks for listening today and if you think we're helping, please spread the word, take care.
Episode details: Many SLPs think of cough as an airway protection mechanism, something patients either have too little of or manage fine. Dr. Miranda Wright, a postdoctoral fellow at the University of Florida's Breathe...
Diagnose, stabilize, and move on to the next chart. That's a common model in acute care, but it's the one this team walked away from. One patient sat trached, decannulated, retrached, and off food, stuck until his care...
What does it look like to bring value as a speech-language pathologist when productivity demands are real and time is limited? In this episode, I talk with Jaimie Anderson, SLP and clinical researcher at one of the...
Why do so many clinicians feel underprepared when they first begin treating dysphagia? In a discussion that applies to SLPs in various settings, Dr. Jordan Hazelwood and I dive into challenges students face when...
This discussion explores what cognitive communication therapy can look like when it moves beyond worksheets and test scores. Guest Lauren Schwabish, an SLP with more than two decades of experience, explains how shifting...